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189classiﬁcation has no use in the absence of endocarditis suspicion, we
did not include controls in this analysis. However, as suggested by
Dr. Tanis and colleagues, we now provide additional data.
We recently analyzed 10 consecutive PHV recipients (3 with
mechanical PHV and 7 with biological PHV) who underwent
PET/CT scanning as part of an investigation of malignancy to
determine the normal ﬂuorodeoxyglucose (FDG) pattern around
PHV. Of them, 2 patients (1 with mechanical PHV and 1 with
biological PHV) had an abnormal FDG uptake 13 and 16
months, respectively, after the PHV implantation, given a speci-
ﬁcity of 80%. This result is in accordance with what we have just
published (1).
Second, false-positive results of PET/CT may occur when this
technique is performed too early after the implantation of the
prosthetic valve. In the present study, the patients with cardiac
surgery performed <1 month earlier were not included to avoid
these false-positive results related to the early post-operative
inﬂammation around the sewing ring, as previously reported (2).
Nevertheless, 14 patients with a PHV implantation <1 year were
included in our work. In this subgroup, among the 3 patients with a
rejected ﬁnal diagnosis of endocarditis, none had an abnormal FDG
uptake. Their PHVs were implanted 66, 210, and 221 days before
the performance of PET/CT. However, the exact delay from which
an abnormal FDG uptake around a PHV could be interpreted as a
criterion of endocarditis remains to be deﬁned. Thus, we
acknowledge that the new PET/CT 2013 modiﬁed Duke criteria
should be used only in patients with suspicion of endocarditis >1
month after the implantation of the PHV. This comment is now
added to the criteria (Table 1).
Third, we agree with Dr. Tanis and colleagues when they
argued that retrospectively electrocardiogram-gated computed
tomography angiography (CTA) is an imaging modality that
may help in the diagnosis of PHV endocarditis, especially in
cases of periannular complications. Although encouraging re-
sults have been published (3,4), this technique has limitations
similar to echocardiography because it remains a morphological
imaging modality without functional data. This is a major issue
when microbiological data are negative and in the case of
absent or doubtful structural lesions. Indeed, CTA may miss
endocarditis at an early stage of the disease and thus may delay
the initiation of treatment (5). In the study of Fagman et al. (4),
of the 13 vegetations detected by transesophageal echocardiogra-
phy, only 7 (54%) were found by CTA. Moreover, all of the 7
vegetations detected by CTA were found by transesophageal
echocardiography (4). Thus, efforts should be made in the future to
develop good-quality imaging techniques that fuse the morpho-
logical accuracy of electrocardiogram-gated CTA (for the valves,
myocardium, and coronary anatomy) and the functional data of
PET (6).
In summary, we believe that we now have strong data to
consider an abnormal FDG uptake in PET/CT imaging as a
major criterion for PHV endocarditis. This result should be used
in patients with PHV implanted for >1 month and must be
interpreted in the clinical and the microbiological contexts.
Although future investigations will allow us to deﬁne the respec-
tive indications and the optimal timing of each new imaging
modality, we strongly believe that the time is coming to include
the results of PET/CT in the Duke criteria for the early diagnosis
of PHV endocarditis. Finally, PET/CT, CTA, and echocardi-
ography must not be considered as concurrent but rather as
complementary techniques. In the future, the 3 techniques willpotentially be used in patients with suspected or conﬁrmed PHV
endocarditis, depending on the clinical presentation and on the
results of initial echographic evaluation, in the era of multi-
modality modality imaging.*Franck Thuny, MD, PhD
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Aggressive ICD Programming
After MADIT-RIT
and ADVANCE III TrialsPowell et al. (1) reported interesting data on survival after shock
therapy in a large cohort of patients enrolled in the ALTITUDE
study. The analysis showed that following a ﬁrst implantable
cardioverter-deﬁbrillator (ICD) shock delivered for ventricular
episodes or atrial ﬁbrillation, there is an increased risk of death. The
same effect is not found when the shock is delivered for a benign
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190rhythm. Powell et al. (1) discussed their results in the context of
MADIT-RIT (Multicenter Automatic Deﬁbrillator Implantation
Trial Reduce Inappropriate Therapy) (2) data assessing whether the
2 results are contradicting and concluded that “combining the re-
sults of the 2 studies, one could conclude that unnecessary ATP
[antitachycardia pacing] may increase mortality, while unnecessary
shocks for sinus tachycardia, SVT [supraventricular tachycardia], or
noise/artifact/oversensing does not appear to affect long-term
survival.” Our recently published experience (3)dnot available at
the time of this publicationdconﬁrms the ﬁnding reported by
Powell et al. (1) that the inappropriate shock itself does not appear
to be associated with a worst outcome. With this further conﬁr-
mation in a real-life population, the question on the possible
explanation for the reduced mortality observed in the MADIT-
RIT study still remains open.
In the MADIT-RIT control arm, ATP therapy was delivered to
treat slow tachycardia, regardless of patients’ previous history of
arrhythmia; this, associated with a lost to follow-up rate greater
than 11%, may potentially have had an effect on the reported
mortality data.
Despite the association of unnecessary ATP therapy with a
worse prognosis cannot be excluded for ATP therapies deliv-
ered to treat slow rhythms, it would be interesting to have
details on the programming zones of patients who died in the
ALTITUDE analysis. We believe that inappropriate and un-
necessary aggressive ICD programming may represent 1 of the
key factors for negative outcome of patients implanted with
ICDs.*Maurizio Gasparini, MD
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Aggressive ICD Programming
After MADIT-RIT
and ADVANCE III TrialsI appreciate the comments by Dr. Gasparini, and I agree with them.
Regarding implantable cardioverter-deﬁbrillator (ICD) programming
in our study, one-half of the patients in the ALTITUDE Survival by
Rhythm Study (1) were taken from the ALTITUDE REDUCES
(Real World Evaluation of Dual-Zone ICD and CRT-D Program-
ming Compared to Single-Zone Programming) study (2) population
inwhichpatientswere retrospectively evaluated for incidence of shocks
and mortality based on ICD programming. The annual incidence of
shocks and pre-shock mortality were highest in patients programmed
with single-zone ventricular ﬁbrillation 170 beats/min (20.1% of
patients received shocks; 2.5% mortality) or dual-zone ventricular
tachycardia (VT)170 beats/min (12.3% of patients received shocks;
2.0% mortality). The lowest annual incidence of shocks (5.5%) and
pre-shock mortality (1.0%) was in the group programmed with dual-
zone VT 200 beats/min. Because it was a retrospective study, we
cannot knowwith certainty if the highermortality in the groups with a
lower programmed VT or ventricular ﬁbrillation zone was related to
ICD programming or if these patients were programmed with lower
zones because of previous episodes of slower ventricular arrhythmias.
Whether or not inappropriate antitachycardia pacing increases mor-
tality is not completely known at this time. However, programming
higher detection rates for primary prevention ICDs and/or using ICD
discriminators to avoid inappropriate shocks and antitachycardia
pacing seems appropriate based on recent studies.*Brian D. Powell, MD
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